The latest financial statement is for the quarter ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -5,290 | -10,670 | -30,483 |
| Accounts payable | -3,596 | 2,197 | 8,447 |
| Accrued interest payable | 2,146 | 2,016 | 5,485 |
| Related party short term advance | - | 0 | - |
| Net cash used in operating activities | -6,740 | -6,457 | -16,551 |
| Proceeds from issuance of convertible notes | 6,740 | 6,457 | 16,392 |
| Net cash provided by financing activities | 6,740 | 6,457 | 16,392 |
| Net change in cash and cash equivalents | 0 | 0 | -159 |
| Cash and cash equivalents at beginning of period | 0 | 159 | - |
| Cash and cash equivalents at end of period | 0 | 0 | - |
Medicale Corp. (MCLE)
Medicale Corp. (MCLE)